Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Nature, Apr 2023 This is a preview of a remote PDF: https://www.nature.com/articles/s41586-023-05790-6.pdf Goethals, Olivia, Kaptein, Suzanne J. F., Kesteleyn, Bart, Bonfanti, Jean-François, Van Wesenbeeck, Liesbeth, Bardiot, Dorothée, Verschoor, Ernst J., Verstrepen, Babs E., Fagrouch, Zahra, Putnak, J.
Correction to: Nature https://doi.org/10.1038/s41586-021-03990-6 Published online 30 June 2021 In this version of this Article originally published, there were errors in Fig. 2 and in the references list. Specifically, in the Fig. 2c colour key, the middle cyan key now reading “JNJ-A07, 10 mg per kg, b.i.d” was missing the number of units, “10,” in the originally published version. Further, refs. 27 and 28 were swapped in the references list; their correct order appears below.
Abstract Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue1,2. There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.